title: Glucagon-like peptide-1 drugs. Use of GLP-1 analogues needs great caution.
authors.forename: John S
authors.initials: JS
authors.lastname: Yudkin
authors.forename: Richard
authors.initials: R
authors.lastname: Lehman
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*
chemical_list: D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents